Expansion of HER2/neu-specific T cells ex vivo following immunization with a HER2/neu peptide-based vaccine

Clinical Breast Cancer

Volumn 2, Issue 1, 2001, Pages 73-79

  Knutson, K L ^a   Disis, M L ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Adoptive T cell therapy; Breast cancer; Cancer vaccines; Cytokines; HER2 neu

Indexed keywords

CANCER VACCINE; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 7; PEPTIDE; TUMOR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; VIRUS VACCINE;

ADOPTIVE IMMUNOTHERAPY; ADVANCED CANCER; ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; BREAST CANCER; CANCER IMMUNIZATION; CANCER PREVENTION; CANCER STAGING; CANCER THERAPY; CELL GROWTH; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEASIBILITY STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LYMPHOCYTE CULTURE; LYMPHOCYTE TRANSFER; MALIGNANT NEOPLASTIC DISEASE; MOUSE; NONHUMAN; ONCOGENE NEU; PHASE 1 CLINICAL TRIAL; T LYMPHOCYTE; TRANSGENIC MOUSE; TUMOR CELL;

EID: 0035012198     PISSN: 15268209     EISSN: None     Source Type: Journal    
DOI: 10.3816/CBC.2001.n.014     Document Type: Article

References (34)

1. NK Nanda EE Sercarz Induction of anti-self-immunity to cure cancer Cell 82 1995 13 17
2. ML Disis MA Cheever HER-2/neu oncogenic protein: issues in vaccine development Crit Rev Immunol 18 1998 37 45
3. DJ Slamon GM Clark SG Wong Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene Science 235 1987 177 182
4. BA Gusterson RD Gelber A Goldhirsch Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group J Clin Oncol 10 1992 1049 1056
5. ML Disis E Calenoff G McLaughlin Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer Cancer Res 54 1994 16 20
6. B Fisk TL Blevins JT Wharton Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines J Exp Med 181 1995 2109 2117
7. GE Peoples PS Goedegebuure R Smith Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/ neu-derived peptide Proc Natl Acad Sci U S A 92 1995 432 436
8. ML Disis KH Grabstein PR Sleath Generation of immunity to the HER-2/neu oncogenic protein in patients with breast and ovarian cancer using a peptide-based vaccine Clin Cancer Res 5 1999 1289 1297
9. KL Knutson K Schiffman ML Disis Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients J Clin Invest 107 2001 477 484
10. ML Disis JR Gralow H Bernhard Peptide-based, but not whole protein, vaccines elicit immunity to HER-2/neu, oncogenic self-protein J Immunol 156 1996 3151 3158
11. M McCutcheon N Wehner A Wensky A sensitive ELISPOT assay to detect low-frequency human T lymphocytes J Immunol Methods 210 1997 149 166
12. CT Guy MA Webster M Schaller Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease Proc Natl Acad Sci U S A 89 1992 10578 10582
13. MA Cheever W Chen Therapy with cultured T cells: principles revisited Immunol Rev 157 1997 177 194
14. MA Roskrow N Suzuki Y Gan Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the treatment of patients with EBVpositive relapsed Hodgkin's disease Blood 91 1998 2925 2934
15. CM Rooney CA Smith CY Ng Use of gene-modified virus-spe-cific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation Lancet 345 1995 9 13
16. HE Heslop CY Ng C Li Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of genemodified virus-specific T lymphocytes Nat Med 2 1996 551 555
17. FR Carbone MW Moore JM Sheil Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides J Exp Med 167 1988 1767 1779
18. ML Disis H Bernhard FM Shiota Granulocyte-macrophage colony-stimulating factor: an effective adjuvant for protein and peptide-based vaccines Blood 88 1996 202 210
19. KL Knutson P Crosby ML Disis Isolation of HER-2/neu (HER2) specific T cell clones from a cancer patient following immunization with a HER2 peptide vaccine Prom Am Assoc Cancer Res 40 1999 310 (Abstract).
20. KL Knutson ML Disis Isolation of HER-2/neu (HER2) specific gamma-delta TCR T cell clones from an HLA-A2 ovarian cancer patient immunized with a peptide-based vaccine FASEB 14 2000 A1006 (Abstract).
21. KL Knutson ML Disis IL-12 enhances in vitro expansion and function of peptide-specific T lymphocytes Proc Am Assoc Cancer Res 41 2000 193 (Abstract).
22. MK Gately BB Desai AG Wolitzky Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor) J Immunol 147 1991 874 882
23. EJ McFarland PA Harding S MaWhinney In vitro effects of IL-12 on HIV-1-specific CTL lines from HIV-1-infected children J Immunol 161 1998 513 519
24. G Trinchieri Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes Blood 84 1994 4008 4027
25. F Gerosa C Paganin D Peritt Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferongamma and interleukin-10 J Exp Med 183 1996 2559 2569
26. LS Casey AH Lichtman M Boothby IL-4 induces IL-2 receptor p75 beta-chain gene expression and IL-2-dependent proliferation in mouse T lymphocytes J Immunol 148 1992 3418 3426
27. K Abdi SH Herrmann CTL generation in the presence of IL-4 is inhibited by free p40: evidence for early and late IL-12 function J Immunol 159 1997 3148 3155
28. AD Roth S Dupuis P Alberto Human recombinant IL-4 decreases the emergence of non-specific cytolytic cells and favours the appearance of memory cells (CD4+CD45RO+) in the IL-2-driven development of cytotoxic T lymphocytes against autologous ovarian tumour cells Clin Exp Immunol 101 1995 362 368
29. R Hofmeister AR Khaled N Benbernou Interleukin-7: physiological roles and mechanisms of action Cytokine Growth Factor Rev 10 1999 41 60
30. P Marrack T Mitchell J Bender T-cell survival Immunol Rev 165 1998 279 285
31. A Takashima H Matsue PR Bergstresser Interleukin-7-dependent interaction of dendritic epidermal T cells with keratinocytes J Invest Dermatol 105 1995 50S 53S
32. MS Hasan EG Kallas EK Thomas Effects of interleukin-15 on in vitro human T cell proliferation and activation J Interferon Cytokine Res 20 2000 119 123
33. X Zhang S Sun I Hwang Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15 Immunity 8 1998 591 599
34. S Bulfone-Paus D Ungureanu T Pohl Interleukin-15 protects from lethal apoptosis in vivo Nat Med 3 1997 1124 1128